Efeito Do Tratamento De Sementes De Cardeiro (Scleronema Micranthum Ducke) Com Fungicida E Inseticida Na Germinação

An experiment was conducted in order to test the effects Aldrin (0,3% e 0,6%) and freniate (0,2% and 0,4%) afone and in various combination on the germination of Cardeiro (Scleronema micranthum Ducke) seeds. Different treatments of the seeds allowed the following conclusions: a) light doses of Aldrin have a stimulant effect on seed germination; b) the percentage of the germinating seeds was reduced with beniate applied in doses exceding 0,2%; c) the germination percentage was increased when seeds were treated with 0,4% Benlate in combination with Aldrin, except when Aldrin was applied in doses greater than 0,3%; d) increasing the dose of freniate in combination with 0,3% Aldrin resulted in a higher percentage of germinating seeds; e) prejudicial effects on seed germination were provoked by increasing the dose of freniate in combination with 0,6% Aldrin.Foi realizado um experimento com objetivo de testar os efeitos de Aldrin (0,3% e 0,6%), Benlate (0,2% e 0,4%) e em combinações na germinação de sementes de Cardeiro (Scleronema micranthumDucke). A análise e interpretação dos resultados obtidos em função dos diferentes tratamentos nas sementes de Cardeiro (Scleronema micranthumDucke), permitiram tirar as seguintes conclusõesa) o tratamento com Aldrin nas sementes mostrou efeito estimulante na germinação com o aumento de doses; b) o tratamento com Benlate quando aplicado em doses superiores a 0,2% provocou redução da porcentagem de germinação; c) nas sementes tratadas com Benlate 0,4% em combinação com Aldrin, exceto quando foram utilizadas doses de Aldrin superiores a 0,3%, ocorreu efeito estimulante na germinação; d) doses crescentes de benlate em combinação com Aldrin 0,3% proporcionaram aumento da porcentagem de germinação; e) doses crescentes de leniate em combinação com Aldrin 0,6% provocaram efeitos prejudiciais à germinação

Omega-3 fatty acids: possible neuroprotective mechanisms in the model of global ischemia in rats

Background. Omega-3 (omega 3) administration was shown to protect against hypoxic-ischemic injury. The objectives were to study the neuroprotective effects of omega 3, in a model of global ischemia. Methods. Male Wistar rats were subjected to carotid occlusion (30 min), followed by reperfusion. The groups were SO, untreated ischemic and ischemic treated rats with omega 3 (5 and 10 mg/kg, 7 days). The SO and untreated ischemic animals were orally treated with 1% cremophor and, 1 h after the last administration, they were behaviorally tested and euthanized for neurochemical (DA, DOPAC, and NE determinations), histological (Fluoro jade staining), and immunohistochemical (TNF-alpha, COX-2 and iNOS) evaluations. The data were analyzed by ANOVA and Newman-Keuls as the post hoc test. Results. Ischemia increased the locomotor activity and rearing behavior that were partly reversed by omega 3. Ischemia decreased striatal DA and DOPAC contents and increased NE contents, effects reversed by omega 3. This drug protected hippocampal neuron degeneration, as observed by Fluoro-Jade staining, and the increased immunostainings for TNF-alpha, COX-2, and iNOS were partly or totally blocked by omega 3. Conclusion. This study showed a neuroprotective effect of omega 3, in great part due to its anti-inflammatory properties, stimulating translational studies focusing on its use in clinic for stroke managing.Faculty of Medicine, Estácio of Juazeiro do Norte (FMJ), Rua Tenente Raimundo Rocha 515, 63040-360 Juazeiro do Norte, CE, BrazilFederal University of Ceará (UFC), Rua Coronel Nunes de Melo 1127, 60430-270 Fortaleza, CE, BrazilFederal University of São Paulo (UNIFESP), Rua Pedro de Toledo 669, 04039-032 São Paulo, SP, BrazilFederal University of São Paulo (UNIFESP), Rua Pedro de Toledo 669, 04039-032 São Paulo, SP, BrazilWeb of Scienc

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

non present